2,072
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Cannabis use by women during pregnancy does not influence infant DNA methylation of the dopamine receptor DRD4

, BSc, , PhD, , PhD, , PhD, , PhD, MD, , PhD, , PhD, , PhD & , PhD show all
Pages 671-677 | Received 17 Oct 2016, Accepted 29 Mar 2017, Published online: 27 Apr 2017

References

  • Roth CK, Satran LA, Smith SM. Marijuana use in pregnancy. Nurs Women’s Health 2015;19:431–437.
  • Calvigioni D, Hurd YL, Harkany T, Keimpema E. Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur Child Adolesc Psychiatry 2014;23:931–941.
  • Cook J, Lloyd-Jones DM, Ogden E, Bonomo Y. Medical use of cannabis: an addiction medicine perspective. Intern Med J 2015;45:677–680.
  • Gunn JKL, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, Ehiri JE. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:e009986.
  • Brown SJ, Mensah FK, Ah Kit J, Stuart-Butler D, Glover K, Leane C, Weetra D, et al. Use of cannabis during pregnancy and birth outcomes in an Aboriginal birth cohort: a cross-sectional, population-based study. BMJ Open 2016;6:e010286.
  • Goldschmidt L, Richardson GA, Willford J, Day NL. Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry 2008;47:254–263.
  • El Marroun H, Hudziak JJ, Tiemeier H, Creemers H, Steegers EA, Jaddoe VW, Hofman A, et al. Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend 2011;118:470–474.
  • Goldschmidt L, Richardson GA, Cornelius MD, Day NL. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol 2004;26:521–532.
  • Sharma P, Murthy P, Bharath MM. Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iran J Psychiatry 2012;7:149–156.
  • Costa MA. The endocannabinoid system: a novel player in human placentation. Reprod Toxicol 2016;61:58–67.
  • Vaiserman AM. Long-term health consequences of early-life exposure to substance abuse: an epigenetic perspective. J Dev Orig Health Dis 2013;4:269–279.
  • Lan N, Chiu MP, Ellis L, Weinberg J. Prenatal alcohol exposure and prenatal stress differentially alter glucocorticoid signaling in the placenta and fetal brain. Neuroscience 2015; 342:167–179.
  • Liu J, Chen J, Ehrlich S, Walton E, White T, Perrone-Bizzozero N, Bustillo J, et al. Methylation patterns in whole blood correlate with symptoms in schizophrenia patients. Schizophr Bull 2014;40:769–776.
  • Morris CV, DiNieri JA, Szutorisz H, Hurd YL. Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment. Eur J Neurosci 2011;34:1574–1583.
  • Rice ME, Patel JC. Somatodendritic dopamine release: recent mechanistic insights. Philos Trans R Soc Lond B Biol Sci 2015;370:1672.
  • Bobadilla L, Vaske J, Asberg K. Dopamine receptor (D4) polymorphism is related to comorbidity between marijuana abuse and depression. Addict Behav 2013;38:2555–2562.
  • Di Ciano P, Pushparaj A, Kim A, Hatch J, Masood T, Ramzi A, Khaled MA, et al. The impact of selective Dopamine D2, D3 and D4 ligands on the rat gambling task. Plos One 2015;10: e0136267.
  • Baker TE, Stockwell T, Barnes G, Haesevoets R, Holroyd CB. Reward sensitivity of ACC as an intermediate phenotype between DRD4-521T and substance misuse. J Cogn Neurosci 2016;28:460–471.
  • Wazana A, Moss E, Jolicoeur-Martineau A, Graffi J, Tsabari G, Lecompte V, Pascuzzo K, et al. The interplay of birth weight, dopamine receptor D4 gene (DRD4), and early maternal care in the prediction of disorganized attachment at 36 months of age. Dev Psychopathol 2015;27:1145–1161.
  • Money KM, Stanwood GD. Developmental origins of brain disorders: roles for dopamine. Front Cell Neurosci 2013:7:260.
  • Markunas CA, Xu Z, Harlid S, Wade PA, Lie RT, Taylor JA, Wilcox AJ. Identification of DNA methylation changes in newborns related to maternal smoking during pregnancy. Environ Health Perspect 2014;122:1147–1153.
  • Joubert BR, Felix JF, Yousefi P, Bakulski KM, Just AC, Breton C, Reese SE, et al. DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis. Am J Hum Genet 2016;98:680–696.
  • Kupers LK, Xu X, Jankipersadsing SA, Vaez A, La Bastide-Van Gemert S, Scholtens S, Nolte IM, et al. DNA methylation mediates the effect of maternal smoking during pregnancy on birthweight of the offspring. Int J Epidemiol 2015;44:1224–1237.
  • Chabarria KC, Racusin DA, Antony KM, Kahr M, Suter MA, Mastrobattista JM, Aagaard KM. Marijuana use and its effects in pregnancy. Am J Obstet Gynecol 2016;215:506.e1–7.
  • Hutchinson D, Wilson J, Allsop A, Elliott E, Najman J, Burns L, Bartu A, et al. The Triple B Pregnancy Cohort Study: a longitudinal study of the relationship between alcohol, tobacco and other substance use during pregnancy and the health and wellbeing of Australian children and families. 2017;epub.
  • Van Mil NH, Steegers-Theunissen RPM, Bouwland-Both MI, Verbiest MMPJ, Rijlaarsdam J, Hofman A, Steegers EA, et al. DNA methylation profiles at birth and child ADHD symptoms. J Psychiatr Res 2014;49:51–59.
  • Januar V, Ancelin ML, Ritchie K, Saffery R, Ryan J. BDNF promoter methylation and genetic variation in late-life depression. Transl Psychiatry 2015;5:e619.
  • Ion R, Bernal AL. Smoking and preterm birth. Reprod Sci 2015;22:918-926.
  • Van De Giessen E, Weinstein JJ, Cassidy CM, Haney M, Dong Z, Ghazzaoui R, Ojeil N, et al. Deficits in striatal dopamine release in cannabis dependence. Mol Psychiatry 2017; 22:68–75.
  • DiNieri JA, Wang X, Szutorisz H, Spano SM, Kaur J, Casaccia P, Dow-Edwards D, Hurd YL. Maternal cannabis use alters ventral striatal Dopamine D2 gene regulation in the offspring. Biol Psychiatry 2011;70:763–769.
  • Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED. Low Dopamine D2/D3 receptor availability is associated with steep discounting of delayed rewards in methamphetamine dependence. Int J Neuropsychopharmacol 2015;18: pyu119.
  • Olsson CA, Moyzis RK, Williamson E, Ellis JA, Parkinson-Bates M, Patton GC, Dwyer T, et al. Gene-environment interaction in problematic substance use: interaction between DRD4 and insecure attachments. Addict Biol 2013;18:717–726.
  • Mallard TT, Doorley J, Esposito-Smythers CL, McGeary JE. Dopamine D4 receptor VNTR polymorphism associated with greater risk for substance abuse among adolescents with disruptive behavior disorders: preliminary results. Am J Addict 2016;25:56–61.
  • Zohsel K, Buchmann AF, Blomeyer D, Hohm E, Schmidt MH, Esser G, Brandeis D, et al. Mothers’ prenatal stress and their children’s antisocial outcomes: a moderating role for the dopamine D4 receptor (DRD4) gene. J Child Psychol Psychiatry 2014;55:69–76.
  • Dadds MR, Schollar-Root O, Lenroot R, Moul C, Hawes DJ. Epigenetic regulation of the DRD4 gene and dimensions of attention-deficit/hyperactivity disorder in children. Eur Child Adolesc Psychiatry 2016;25:1081–1089.
  • Australian Institute of Health and Welfare. National Drug Strategy Household Survey Detailed Report 2013. Australian Institute of Health and Welfare; 2014.
  • El Marroun H, Tiemeier H, Steegers EA, Jaddoe VW, Hofman A, Verhulst FC, van den Brink W, Huizink AC. Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry 2009;48:1173–1181.
  • Wong CC, Caspi A, Williams B, Craig IW, Houts R, Ambler A, Moffitt TE, Mill J. A longitudinal study of epigenetic variation in twins. Epigenetics 2010;5:516–526.